Acceso abierto

Supplementary scales for the school-age forms of the Achenbach System of Empirically Based Assessment rated by adolescents, parents, and teachers: Psychometric properties in German samples

, ,  y   
05 may 2025

Cite
Descargar portada

Scale scores and internal consistencies in clinic and community sample across informants

CBCL/6–18 YSR/11–18 TRF/6–18
Origin Clinic Community Clinic Community Clinic
N 1288 2471 755 1797 836
Age (years)
M 11.5 12.3 14.0 13.9 10.9
(SD) (3.3) (3.3) (2.1) (2.2) (3.1)
Male% 64.7 50.5 56.4 51.4 69.9

Scale (nit) Ω rit(Range) M SD Ω rit(Range) M SD (nit) Ω rit(Range) M SD Ω rit(Range) M SD (nit) Ω rit(Range) M SD
SPS (14) .72 (.18-.50) 9.07 4.56 .74 (.29-.44) 2.86 2.90 (14) .79 (.23-.61) 8.89 5.02 .78 (.26-50) 4.57 3.81 (13) .69 (.21-.53) 5.98 4.14
OCP (8) .69 (.26-.51) 3.18 2.86 .54 (.19-.37) 0.80 1.27 (8) .74 (.33-.55) 3.92 3.37 .64 (.23-.44) 1.56 1.96 (8) .66 (.26-.45) 1.82 2.36
SCT1,2 (4) .66 (.34-.54) 1.79 1.77 .50 (.27-.33) 0.51 0.91 (5) .81 (.47-.66) 2.73 2.65
PQS3 (14) .73 (.14-.47) 18.83 4.37 .87 (.29-.68) 17.09 6.19
DRS1 (41) .89 (.14-.60) 24.32 12.22 .89 (.19-.53) 8.31 7.57 (39) .89 (.20-.63) 21.33 11.34 .91 (.22-.58) 12.71 9.51 (62) .95A (-.02-.71) 30.79 20.59
DRS2 24.30 11.98 8.23 7.54 22.11 11.61 12.93 9.71 29.08 19.52
ASD1 (9) .58 (.13-.43) 3.56 2.81 .52 (.15-.33) 0.98 1.42 (9) .51 (.12-.31) 3.57 2.70 .56 (.22-.33) 1.65 1.89 (9) .63 (.15-.48) 2.77 2.67
ASD2 (10) .64 (.20-.43) 3.99 3.13 .60 (.20-.37) 1.08 1.59 (9) .58 (.22-.39) 3.97 2.88 .60 (.23-.37) 1.82 1.99 (10) .74 (.29-.53) 3.74 3.48
ASD31 (15) .78 (.21-.55) 6.76 4.87 .76 (.19-.46) 1.97 2.63 (14) .72 (.18-.45) 6.69 4.37 .75 (.22-.45) 3.40 3.30 (15) .80 (.22-.59) 6.02 4.95
MAS1 (19) .79 (.13-.59) 8.26 5.25 .76 (.13-.49) 2.73 3.04 (17) .75 (.19-.46) 7.94 4.78 .81 (.21-.49) 4.93 4.13 (15) .87 (.03-.73) 6.07 5.35

Mean differences between clinic and community samples for the CBCL/6–18 and YSR/11–18_

CBCL/6–18 YSR/11–18
Origin N Clinic 1288 Community 2471 Clinic 755 Community 1797 (nPQS = 1791)

Scale M SD M SD t df d M SD M SD tL df d
SPS 9.07 4.56 2.86 2.90 44.42 1843.22 1.75 8.89 5.02 4.57 3.81 21.24 1135.13 1.03
OCP 3.18 2.86 0.80 1.27 28.43 1558.42 1.21 3.92 3.37 1.56 1.96 17.96 974.37 0.96
SCT1 1.79 1.77 0.51 0.91 24.25 1649.10 1.00
PQS2 18.83 4.37 17.09 6.19 8.02 1974.84 0.30
DRS1 24.32 12.22 8.32 7.57 42.92 1816.33 1.70 21.33 11.34 12.71 9.51 18.35 1220.90 0.85
DRS2 24.30 11.98 8.23 7.54 43.80 1831.65 1.73 22.11 11.62 12.93 9.71 19.09 1217.43 0.89
ASD1 3.56 2.81 0.98 1.42 30.99 1640.01 1.29 3.57 2.70 1.65 1.89 17.77 1077.19 0.89
ASD2 3.99 3.13 1.08 1.59 31.34 1638.54 1.30 3.97 2.88 1.82 1.99 18.74 1069.62 0.94
ASD3 6.76 4.87 1.97 2.63 32.84 1686.72 1.34 6.69 4.37 3.40 3.30 18.59 1131.57 0.90
MAS 8.26 5.25 2.73 3.04 34.83 1748.99 1.40 7.94 4.78 4.93 4.13 15.09 1249.71 0.69

Mean differences of supplementary scales between clinic subgroups with and without the nearest respective diagnosis1

CBCL/6–18 YSR/11–18 TRF/6–18



Scale Group n M SD t df p d n M SD t df p d n M SD t df p d
OCP Y 74 6.85 3.37 - 78.70 <.001 1.44 62 6.95 3.62 - 753 <.001 1.02 32 3.25 2.27 -3.52 834 <.001 0.64
N 1214 2.96 2.67 9.77w 693 3.65 3.22 7.67 804 1.76 2.34
ASD1 Y 68 6.96 3.48 - 71.36 <.001 1.33 29 5.14 3.17 - 753 .001 0.61 53 5.57 3.01 -8.16 834 <.001 1.16
N 1220 3.37 2.64 8.37w 726 3.50 2.66 3.22 783 2.58 2.54
ASD2 Y 68 7.79 3.60 - 1286 <.001 1.34 29 5.10 3.31 - 753 .030 0.41 53 7.43 4.05 - 56.74 <.001 1.18
N 1220 3.78 2.96 10.74 726 3.92 2.85 2.17 783 3.49 3.29 6.93w
ASD3 Y 68 12.24 4.96 -9.87 1286 <.001 1.23 29 8.59 4.62 - 753 .017 0.45 53 10.25 5.58 -6.60 834 <.001 0.94
N 1220 6.45 4.69 726 6.61 4.34 2.39 783 5.73 4.77

Pearson Correlations of supplement scales with age and gender within both samples for each informant

CBCL/6–18R YSR/11–18R TRF/6–18R
Origin Clinic Community Clinic Community Clinic
N 1288 2471 755 1797 836
nfemale 455 1224 326 874 251
nmale 833 1247 429 923 585

Scale r CIr r CIr r CIr r CIr r CIr
SPS Age .06 [.00, .11] -.01 [-.05, .03] .21* [.14, .28] .06 [.01, .10] .07 [<.01, .14]
Gender1 .06 [<.01, .12] .01 [-.03, .05] .29* [.22, .35] .08* [.04, .13] -.08 [-.15, -.02]
OCP Age .11* [.05, .16] .05 [<.01, .09] .27* [.20, .33] .11* [.06, .15] .06 [<-.01, .13]
Gender .12* [.07, .18] .01 [-.03, .05] .32* [.26, .38] .07* [.02, .11] .02 [-.05, .08]
SCT2 Age .09* <-.01 [-.06, .05] - - .08 [.01, .14]
Gender <.01 [-.05, .06] -.02 [-.06, .02] - - -.09* [-.16, -.02]
PQS3 Age - - -.10* [-.17, -.03] .12* [.08, .17] -
Gender - - -.04 [-.11, .03] .07* [.03, .12] -
DRS1 Age -.10* [-.15, -.05] -.04 [-.08, <-.01] .16* [.09, .23] .06 [.01, .10] -.11* [-.17, -.04]
Gender -.15* [-.20, -.09] -.07* [-.11. -.03] .18* [.11, .24] .04 [-.01, .08] -.27* [-.33, -.20]
DRS2 Age -.09* [-.14, -.03] -.04 [-.08, <.01] .15* [.08, .22] .04 [<-.01, .09] -.09* [-.16, -.02]
Gender -.15* [-.20, -.10] -.07* [-.11, -.03] .18* [.11, .24] .04 [-.01, .08] -.24* [-.31, -.18]
ASD1 Age .04 [-.01, .10] -.02 [-.06, .02] .18* [.11, .25] .02 [-.02, .07] -.01 [-.08, .06]
Gender -.06 [-.12, -.01] -.01 [-.05, .03] .15* [.08, .22] .06 [<.01, .10] -.14* [-.21, -.07]
ASD2 Age .07* [.02, .13] .01 [-.03, .05] .24* [.18, .31] .08* [.03, .12] .01 [-.05, .08]
Gender -.03 [-.08, .03] -.03 [-.07, .01] .18* [.11, .25] .07* [.02, .11] -.11* [-.18, -.04]
ASD3 Age .08* [.03, .13] -.01 [-.05, .03] .27* [.20, .34] .07* [.02, .11] .04 [-.03, .11]
Gender .01 [-.05, .07] <.01 [-.04, .04] .20* [.13, .27] .07* [.03, .12] .08 [-.15, -.01]
MAS Age -.20* [-.25, -.14] -.07* [-.11, .03] .07 [< -.01, .14] .06* [.02, .11] -.15* [-.21, -.08]
Gender -.25* [-.30, -.19] -.10* [-.14, -.06] .07 [<.01, .14] -.02 [-.07, .02] -.28* [-.34, -.22]

Cross-informant Pearson correlations in community and clinic sample_

Community Clinic
N CBCLxYSR CBCLxYSR CBCLxTRF TRFxYSR
1757 705 799 396

Scale r CIr r CIr r CIr r CIr
SPS .50 [.47,.54] .35 [.28,.41] .20 [.13,.27] .09+ [-.01,.18]
OCP .35 [.31,.39] .41 [.35,.47] .20 [.14,.27] .21 [.12,.30]
SCT1 - .33 [.26,.39] - -
DRS1 .53 [.50,.57] .34 [.27,.40] .35 [.29,.41] .15 [.05,.24]
DRS2 .53 [.48,.56] .33 [.26,.39] .33 [.27,.39] .14 [.04,.23]
ASD1 .39 [.35,.43] .33 [.26,.40] .35 [.28,.41] .19 [.10,.29]
ASD2 .38 [.34,.42] .30 [.24,.37] .35 [.29,.41] .13 [.04,.23]
ASD3 .44 [.41,.48] .34 [.27,.41] .38 [.32,.44] .19 [.09,.28]
MAS .46 [.42,.50] .36 [.29,.42] .40 [.34,.46] .25 [.15,.34]
Idioma:
Inglés
Calendario de la edición:
1 veces al año
Temas de la revista:
Medicina, Ciencias médicas básicas, Ciencias médicas básicas, otros